Drug trial for untreatable chest pain withdrawn before starting
NCT ID NCT04306237
Summary
This study aimed to test whether a new drug called IMB-1018972 could help people with severe, treatment-resistant chest pain (refractory angina) exercise longer and have fewer symptoms. It was designed as a Phase 2 trial where participants would be randomly assigned to receive either the drug or a placebo for comparison. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY ANGINA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imbria Investigational Site
Boston, Massachusetts, 02110, United States
Conditions
Explore the condition pages connected to this study.